Home Blog Page 232

Blog

Pharma Marketing Blog

Random

Social Media Listening by Pharma: Do the Ends Justify the Means?

Pharma Guy - November 7, 2013

Drug Risks: Consumers Less Concerned than Docs

Pharma Guy - June 2, 2006

Restless Brush Syndrome: Lessons for Requip Marketers

Pharma Guy - June 5, 2006

The Secret Lives of DTC Critters

Pharma Guy - January 15, 2009

Paula Deen Does Not Know Her Blood Sugar Numbers

Pharma Guy - April 12, 2012

Pfizer & PhRMA Lobby in Support of SOPA

Pharma Guy - January 18, 2012

Pharma Celebrity Spokespersons: Unrepentant, Secretive, and (Expletive Deleted)!

Pharma Guy - February 26, 2012

For Pharma Marketers, Celebrities + “Social Media” = Gold Mine!

Pharma Guy - July 29, 2015

Dining at Pharma’s Table

Pharma Guy - March 26, 2007

Lilly Sales Reps Learn Marketing Lessons From Disney’s Animal Keepers

Pharma Guy - January 10, 2012

1...231232233...241 Page 232 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026